GeneDx Holdings (WGS) Cash & Equivalents Growth (3y) (2023 - 2026)
GeneDx Holdings (WGS) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 70.63% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | -27.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.26% |
| Mar 31, 2026 | -22.52% |
| Dec 31, 2025 | -5.38% |
| Sep 30, 2025 | -20.56% |
| Jun 30, 2025 | -36.14% |
| Mar 31, 2025 | -31.85% |
| Dec 31, 2024 | -40.30% |
| Sep 30, 2024 | -49.93% |
| Jun 30, 2024 | 28.38% |
| Mar 31, 2024 | 12.57% |
| Dec 31, 2023 | -2.68% |
| Sep 30, 2023 | 324.80% |